Browse Events 
Search by Keywords
Recorded Webinar: STI Testing and Treatment as Part of HIV Prevention (2/27/24)
Description
Recorded on February 27th, 2024Click “Register” to access recording.
Dr. Kevin Ard presents updated recommendations for STI testing and treatment, as well as innovations in the field such as post-exposure Doxycycline and low- threshold testing options for STIs as a ...
Intented Audience
Contact
Dennis Adey
Recorded on February 27th, 2024Click “Register” to access recording.
Dr. Kevin Ard presents updated recommendations for STI testing and treatment, as well as innovations in the field such as post-exposure Doxycycline and low- threshold testing options for STIs as a ...
Intented Audience
Contact
Dennis Adey
Sponsored by The Fenway Institute
Fee: None
Recorded Webinar: Innovative Methods for Delivering Pre-Exposure Prophylaxis (PrEP) Care (12/1/2023)
Description
Click "Register" to access the recording.
Recorded on December 1, 2023.
Presented by Dr. Kevin Ard, participants will learn about innovative approaches to HIV prevention using a status-neutral framework with information on telehealth for pre-exposure prophylaxis (PrEP), PrEP On Demand, and more. ...
Intented Audience
Contact
Gavin Granitto
Click "Register" to access the recording.
Recorded on December 1, 2023.
Presented by Dr. Kevin Ard, participants will learn about innovative approaches to HIV prevention using a status-neutral framework with information on telehealth for pre-exposure prophylaxis (PrEP), PrEP On Demand, and more. ...
Intented Audience
Contact
Gavin Granitto
Sponsored by The Fenway Institute
Fee: None
Recorded: What’s Next in PrEP? New Strategies for HIV Prevention (5/24/2023)
Description
Click "Register" to access Recording.
Just over 10 years ago, the first agent for HIV pre-exposure prophylaxis was approved in the United States. Since then, the landscape of PrEP has shifted, with approval of additional PrEP medications and growth of low-threshold ...
Intented Audience
Physicians, nurses, C-suite leadership, CFOs, PrEP navigators, whole care team
Contact
jbruno@fenwayhealth.org
Click "Register" to access Recording.
Just over 10 years ago, the first agent for HIV pre-exposure prophylaxis was approved in the United States. Since then, the landscape of PrEP has shifted, with approval of additional PrEP medications and growth of low-threshold ...
Intented Audience
Physicians, nurses, C-suite leadership, CFOs, PrEP navigators, whole care team
Contact
jbruno@fenwayhealth.org
Sponsored by The Fenway Institute
Fee: None
Page 1 of 1, showing 3 records out of 3 total, starting on record 1, ending on 3
< previousnext >